SCHEMBL1659299

SCHEMBL1659299

Cc1ccccc1NC(=O)Nc1cccc(NC(=O)Nc2cccc(NC(=O)Nc3ccccc3C)c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 3/20 1.00
RAB9A P51151 7/20 0.64
NPC1 O15118 6/20 0.64
MAPT P10636 3/20 0.60
KMT2A Q03164 2/20 0.60
HTT P42858 2/20 0.60
MEN1 O00255 1/20 0.60
ITGB1 P05556 2/20 0.60
ITGA4 P13612 2/20 0.60
IMPDH2 P12268 1/20 0.59
POLB P06746 4/20 0.59
LMNA P02545 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
ALDH1A1 P00352 2/20 0.56
HPGD P15428 1/20 0.56
TP53 P04637 1/20 0.55
GAA P10253 1/20 0.55
ALOX15 P16050 1/20 0.55
HSD17B10 Q99714 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11918074 1.00 DDX3X (1.00) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL1655857 0.92 DDX3X (0.85) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL10192076 0.92 DDX3X (0.84) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL812756 0.89 DDX3X (0.80) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL17079603 0.89 DDX3X (0.79) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL1657638 0.89 DDX3X (1.00) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL17079616 0.89 DDX3X (0.79) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL17079631 0.89 DDX3X (0.79) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL34468112 0.88 DDX3X (0.77) DDX3XRAB9ANPC1MAPTKMT2A
SCHEMBL1275926 0.87 RAB9A (0.75) DDX3XRAB9ANPC1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 US disclosed
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 US disclosed
WO-2011039735-A2 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2011-04-07 WO disclosed
WO-2011039735-A2 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2011-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF DDX3X, DDX21, DDX39B DDX3X 1/4885RAB9A 2819/4885NPC1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.